Synthetic archaeosome vaccines containing triglycosylarchaeols can provide additive and long-lasting immune responses that are enhanced by archaetidylserine

From National Research Council Canada

DOIResolve DOI: https://doi.org/10.1155/2012/513231
AuthorSearch for: 1; Search for: 1; Search for: 1; Search for: 1; Search for: 1
Affiliation
  1. National Research Council of Canada. NRC Institute for Biological Sciences
FormatText, Article
SubjectArchaea; Halobacterium salinarum; Mus; antibody; archaeol lipid; cancer vaccine; glycerol ether; glycolipid; immunological adjuvant; tumor antigen; blood; C57BL mouse; CD4+ T lymphocyte; CD8+ T lymphocyte; chemistry; Halobacterium salinarum; immunology; isolation and purification; mouse; neoplasm; pathology; Adjuvants, Immunologic; Antibodies; Antigens, Neoplasm; Cancer Vaccines; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Glyceryl Ethers; Glycolipids; Halobacterium salinarum; Mice; Mice, Inbred C57BL; Neoplasms
Abstract
Publication date
In
LanguageEnglish
Peer reviewedYes
NPARC number21269257
Export citationExport as RIS
Report a correctionReport a correction (opens in a new tab)
Record identifiere74241ce-40c2-42f1-827f-d61287ebc165
Record created2013-12-12
Record modified2020-04-21
Date modified: